Ohtani H - Search Results

1

In silico evaluation of warfarin-bucolome therapy.

Ohtani H, Hakoda R, Imaoka A, Akiyoshi T. Ohtani H, et al. Biopharm Drug Dispos. 2016 May;37(4):233-42. doi: 10.1002/bdd.2008. Biopharm Drug Dispos. 2016. PMID: 27214159

2

Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.

Tsujikawa K, Dan Y, Nogawa K, Sato H, Yamada Y, Murakami H, Ohtani H, Sawada Y, Iga T. Tsujikawa K, et al. Among authors: ohtani h. Biopharm Drug Dispos. 2003 Apr;24(3):105-14. doi: 10.1002/bdd.343. Biopharm Drug Dispos. 2003. PMID: 12673668

3

Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants.

Akiyoshi T, Saito T, Murase S, Miyazaki M, Murayama N, Yamazaki H, Guengerich FP, Nakamura K, Yamamoto K, Ohtani H. Akiyoshi T, et al. Among authors: ohtani h. Drug Metab Dispos. 2011 Apr;39(4):724-8. doi: 10.1124/dmd.110.036780. Epub 2011 Jan 6. Drug Metab Dispos. 2011. PMID: 21212239 Free PMC article.

4

Bottom-up modeling and simulation of tacrolimus clearance: prospective investigation of blood cell distribution, sex and CYP3A5 expression as covariates and assessment of study power.

Ohtani H, Barter Z, Minematsu T, Makuuchi M, Sawada Y, Rostami-Hodjegan A. Ohtani H, et al. Biopharm Drug Dispos. 2011 Dec;32(9):498-506. doi: 10.1002/bdd.777. Epub 2011 Nov 8. Biopharm Drug Dispos. 2011. PMID: 22028295 Clinical Trial.

5

Mechanism-based inhibition profiles of erythromycin and clarithromycin with cytochrome P450 3A4 genetic variants.

Akiyoshi T, Ito M, Murase S, Miyazaki M, Guengerich FP, Nakamura K, Yamamoto K, Ohtani H. Akiyoshi T, et al. Among authors: ohtani h. Drug Metab Pharmacokinet. 2013;28(5):411-5. doi: 10.2133/dmpk.dmpk-12-rg-134. Epub 2013 Mar 19. Drug Metab Pharmacokinet. 2013. PMID: 23514827 Free article.

6

Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population.

Akiyoshi T, Shimomura Y, Masuda S, Okamoto Y, Hiura S, Kato H, Asayama T, Ohtani H. Akiyoshi T, et al. Among authors: ohtani h. Drug Metab Pharmacokinet. 2013;28(5):446-50. doi: 10.2133/dmpk.dmpk-12-nt-095. Epub 2013 Apr 9. Drug Metab Pharmacokinet. 2013. PMID: 23574887 Free article.

7

Decrease in ciprofloxacin absorption by polyvalent metal cations is not fully attributable to chelation or adsorption.

Imaoka A, Hattori M, Akiyoshi T, Ohtani H. Imaoka A, et al. Among authors: ohtani h. Drug Metab Pharmacokinet. 2014;29(5):414-8. doi: 10.2133/dmpk.dmpk-14-rg-001. Epub 2014 May 6. Drug Metab Pharmacokinet. 2014. PMID: 24806820 Free article.

8

Prediction of the extent and variation of grapefruit juice-drug interactions from the pharmacokinetic profile in the absence of grapefruit juice.

Kogure N, Akiyoshi T, Imaoka A, Ohtani H. Kogure N, et al. Among authors: ohtani h. Biopharm Drug Dispos. 2014 Oct;35(7):373-81. doi: 10.1002/bdd.1904. Epub 2014 Aug 30. Biopharm Drug Dispos. 2014. PMID: 24898424

9

[Current status of illegal trade in pharmaceutical products on Internet auction sites in Japan and responses of site administrators to such transactions].

Ohtani H, Imaoka A, Akiyoshi T. Ohtani H, et al. Yakugaku Zasshi. 2015;135(3):529-34. doi: 10.1248/yakushi.14-00238. Yakugaku Zasshi. 2015. PMID: 25759061 Free article. Japanese.

10

Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6.

Akiyoshi T, Ishiuchi M, Imaoka A, Ohtani H. Akiyoshi T, et al. Among authors: ohtani h. Drug Metab Pharmacokinet. 2015 Aug;30(4):321-4. doi: 10.1016/j.dmpk.2015.04.003. Epub 2015 Apr 25. Drug Metab Pharmacokinet. 2015. PMID: 26195224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,003 results

Search Page

Filters